The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
Review
[키워드] acute respiratory distress
addition
addressed
Angiotensin-converting enzyme
Antibody-dependent enhancement
bind
cause
challenge
change
characterized
Clinical management
clinical manifestation
clinically
Complete
complications of COVID-19
Coronavirus disease-19
COVID-19
COVID-19 patient
COVID-19 patients
current
Cytokine storm
described
develop
development
drug
effective
eosinophil
greater
Hypothesis
Immunity
immunopathological
include
individual
Infection
infiltration
lack
lung
lymphopenia
management
mechanism
mechanisms
membrane
molecular
mononuclear cell
mutant
pathogenesis of SARS-CoV-2
pathophysiology
patients
Pneumonia
Prevent
protease
PROTECT
provide
reduce
Replication
Research
respiratory
S glycoprotein
SARS-CoV-2
serological test
Spread
status
T cell
tested
the antibody response
therapeutic
therapeutic intervention
Treatment
understanding
Vaccine
variant
variants of SARS-CoV-2
variations
Viral load
virulence
virus
virus transmission
[DOI] 10.1155/2021/8160860 PMC 바로가기 [Article Type] Review
[DOI] 10.1155/2021/8160860 PMC 바로가기 [Article Type] Review